Works matching DE "CANDESARTAN"

Results: 312

The Solubility of Ethyl Candesartan in Mono Solvents and Investigation of Intermolecular Interactions.

Published in:

Liquids (2673-8015), 2022, v. 2, n. 4, p. 404, doi. 10.3390/liquids2040023

By:

Du, Cunbin

Publication type:

Article

Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease.

Published in:

Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac270

By:

Hajjar, Ihab;
Okafor, Maureen;
Limeng Wan;
Zhiyi Yang;
Nye, Jonathon A.;
Bohsali, Anastasia;
Shaw, Leslie M.;
Levey, Allan I.;
Lah, James J.;
Calhoun, Vince D.;
Moore, Reneé H.;
Goldstein, Felicia C.

Publication type:

Article

Formulation of Candesartan Cilexetil Nanoparticles by Ionotropic Gelation Method Using Ultrasonication.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 3, p. 728, doi. 10.5530/ijper.57.3.88

By:

Bisht, Tanuja;
Bolmal, U. B.;
Nainwal, Nidhi

Publication type:

Article

Liquisolid Compact Tablet of Candesartan Cilexetil with Enhanced Solubility using Neusilin US2, Aerosil 200 and Transcutol HP.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2019, v. 53, n. 3, p. 457, doi. 10.5530/ijper.53.3.78

By:

Argade, Pallavi;
Patole, Vinita Chandrakant;
Pandit, Ashlesha Pravin

Publication type:

Article

Poly(lactic acid-co-glycolic acid) Nanospheres Improved the Oral Delivery of Candesartan Cilexetil.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2018, v. 52, n. 3, p. 571, doi. 10.5530/ijper.51.4.86

By:

Nair, Anroop B.;
Al-Dhubiab, Bandar E.;
Shah, Jigar;
Attimarad, Mahesh;
Harsha, Sree

Publication type:

Article

Poly(lactic acid-co-glycolic acid) Nanospheres Improved the Oral Delivery of Candesartan Cilexetil.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2017, v. 51, n. 4, p. 571, doi. 10.5530/ijper.51.4.86

By:

Nair, Anroop B.;
Al-Dhubiab, Bandar E.;
Shah, Jigar;
Attimarad, Mahesh;
Harsha, Sree

Publication type:

Article

THE PLASMA LEVEL OF SOLUBLE ENDOGLIN IN HYPERTENSIVE PATIENTS UNDERGOING LONG-TERM TREATMENT WITH CANDESARTAN.

Published in:

Farmacia, 2022, v. 70, n. 1, p. 90, doi. 10.31925/farmacia.2022.1.14

By:

BUDA, VALENTINA;
ANDOR, MINODORA;
TUDOR, ANCA;
CREŢU, OCTAVIAN;
CRISTESCU, CARMEN;
DANCIU, CORINA;
LEDEŢI, IONUT;
CRAINICEANU, ZORIN;
ONEL, MIRCEA;
BORDEJEVIC, DIANA AURORA;
TOMESCU, MIRELA CLEOPATRA;
SUCIU, OANA;
PETRESCU, LUCIAN;
MAN, DANA EMILIA

Publication type:

Article

SYNERGISTIC EFFECS OT THE DOXEPIN-CANDESARTAN COMBINATION ON THE THERMOALGESIC SENSIBILITY IN MICE.

Published in:

Farmacia, 2017, v. 65, n. 5, p. 726

By:

ABABEI, DANIELA CARMEN;
CHIRIAC, SORIN BEȘCHEA;
BILD, WALTHER;
SOLCAN, CARMEN;
LUCA, ANDREI;
RUSU, RĂZVAN NICOLAE;
BULEA, DELIA;
BILD, VERONICA

Publication type:

Article

THE SIMULTANEOUS DETERMINATION OF CANDESARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, FROM A MIXTURE AND PHARMACEUTICAL FORMULATIONS.

Published in:

Farmacia, 2016, v. 64, n. 4, p. 612

By:

MOISEI, ANCA;
TOTAN, MARIA;
GLIGOR, FELICIA GABRIELA;
CRĂCIUN, ISABELA;
TODORAN, NICOLETA;
CHIŞ, AURELIA ADRIANA;
POPA, DANIELA ELENA

Publication type:

Article

Innovative buccal film delivery system for hypertension: Combining candesartan and hydrochlorothiazide.

Published in:

Journal of Biomaterials Applications, 2025, v. 39, n. 9, p. 1014, doi. 10.1177/08853282251317853

By:

Tarawneh, Ola;
Kanan, Aisha;
Al-Zyoud, Walid;
Khanfar, Mohammad;
Hailat, Mohammad;
Alhusban, Ala A.;
Jaber, Razan Abu

Publication type:

Article

Hope for primary cardiovascular prevention with the HOPE (Heart Outcomes Prevention Evaluation)-3 trial findings.

Published in:

Global Cardiology Science & Practice, 2016, v. 2016, n. 2, p. 1, doi. 10.21542/gcsp.2016.13

By:

Al Suwaidi, Jassim

Publication type:

Article

Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39779-y

By:

Ito, Shin;
Takahama, Hiroyuki;
Asakura, Masanori;
Abe, Yukio;
Ajioka, Masayoshi;
Anzai, Toshihisa;
Arikawa, Takuo;
Hayashi, Takaharu;
Higashino, Yorihiko;
Hiramitsu, Shinya;
Iwahashi, Noriaki;
Izumi, Chisato;
Kimura, Kazuo;
Kinugawa, Koichiro;
Kioka, Hidetaka;
Lim, Young-Jae;
Matsuoka, Ken;
Matsuoka, Satoshi;
Motoki, Hirohiko;
Nakamura, Sunao

Publication type:

Article

A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1087913

By:

Fan Liu;
Hanxi Yi;
Lei Wang;
Zeneng Cheng;
Guoqing Zhang

Publication type:

Article

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection.

Published in:

Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.688772

By:

Xu, Lanlan;
She, Pengfei;
Chen, Lihua;
Li, Shijia;
Zhou, Linying;
Hussain, Zubair;
Liu, Yaqian;
Wu, Yong

Publication type:

Article

Candesartan prevents impairment of recall caused by repeated stress in rats.

Published in:

Psychopharmacology, 2013, v. 225, n. 2, p. 421, doi. 10.1007/s00213-012-2829-3

By:

Braszko, Jan;
Wincewicz, Dominik;
Jakubów, Piotr

Publication type:

Article

Circadian Differences in the Contribution of the Brain Renin-Angiotensin System in Genetically Hypertensive Mice.

Published in:

Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.00231

By:

Jackson, Kristy L.;
Marques, Francine Z.;
Lim, Kyungjoon;
Davern, Pamela J.;
Head, Geoffrey A.

Publication type:

Article

The GP study in non-controlled hypertensive patients, de adhesion and dose therapeutics matters?

Published in:

Blood Pressure, 2024, v. 33, n. 1, p. 1, doi. 10.1080/08037051.2024.2377157

By:

Mesquita Bastos, José

Publication type:

Article

Development and validation of a dissolution test with reversed-phase high performance liquid chromatographic analysis for Candesartan cilexetil in tablet dosage forms.

Published in:

Arabian Journal of Chemistry, 2016, v. 9, p. S867, doi. 10.1016/j.arabjc.2011.09.011

By:

Kamalakkannan, Vairappan;
Puratchikody, Ayarivan;
Ramanathan, Lakshmanan;
Jayapraba, Sundaravadivelu

Publication type:

Article

Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model.

Published in:

Journal of Medicine & Life, 2022, v. 15, n. 12, p. 1553, doi. 10.25122/jml-2021-0227

By:

Ghafil, Fadhaa Abdulameer;
Kadhim, Samah Abdulridha Abdul;
Majeed, Sahar;
Qassam, Heider;
Hadi, Najah Rayish

Publication type:

Article

COMPARATIVE STUDY ON THE EFFICIENCY OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS IN REDUCING SERUM C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.

Published in:

Therapeutics, Pharmacology & Clinical Toxicology, 2010, v. 14, n. 2, p. 108

By:

Cioca, Gabriela;
Boitan, Minerva;
Zaharie, Alina;
Safta, L.

Publication type:

Article

Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.

Published in:

PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0303900

By:

Ali, Israa Saad Mustafa;
Sajad, Uday Aziz;
Abdul Rasool, Bazigha K.

Publication type:

Article

Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia.

Published in:

Neurochemical Research, 2018, v. 43, n. 10, p. 1869, doi. 10.1007/s11064-018-2604-x

By:

Ishrat, Tauheed;
Soliman, Sahar;
Eldahshan, Wael;
Pillai, Bindu;
Ergul, Adviye;
Fagan, Susan C.

Publication type:

Article

Candesartan Reduces the Hemorrhage Associated with Delayed Tissue Plasminogen Activator Treatment in Rat Embolic Stroke.

Published in:

Neurochemical Research, 2013, v. 38, n. 12, p. 2668, doi. 10.1007/s11064-013-1185-y

By:

Ishrat, Tauheed;
Pillai, Bindu;
Ergul, Adviye;
Hafez, Sherif;
Fagan, Susan C.

Publication type:

Article

Effect of different splitting techniques on the characteristics of divided tablets of five commonly split drug products in Jordan.

Published in:

Pharmacy Practice (1886-3655), 2020, v. 18, n. 2, p. 1, doi. 10.18549/PharmPract.2020.2.1776

By:

GHARAIBEH, Shadi F.;
TAHAINEH, Linda

Publication type:

Article

New Stability Indicating Method for the Simultaneous Determination of Impurities Present in Candesartan Cilexetil and Hydrochlorothiazide Tablets by Ultra Performance Liquid Chromatography with Photo Diode Array Detector.

Published in:

Eurasian Journal of Analytical Chemistry, 2017, v. 12, n. 2, p. 127, doi. 10.12973/ejac.2017.00159a

By:

Krishna, M. V. V. N. Murali;
Rao, Sumathi V.;
Venugopal, N. V. S.;
Mantena, Bhaskara P. V.

Publication type:

Article

Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.

Published in:

Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0185-4

By:

Danigo, Aurore;
Nasser, Mohamad;
Bessaguet, Flavien;
Javellaud, James;
Oudart, Nicole;
Achard, Jean-Michel;
Demiot, Claire

Publication type:

Article

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report.

Published in:

Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-71

By:

Suzuki, Hirofumi;
Sakamoto, Masaya;
Hayashi, Takeshi;
Iuchi, Hiroyuki;
Ohashi, Kennosuke;
Isaka, Tsuyoshi;
Sakamoto, Noriko;
Kayama, Yosuke;
Tojo, Katsuyoshi;
Yoshimura, Michihiro;
Utsunomiya, Kazunori

Publication type:

Article

Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.

Published in:

Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 118, doi. 10.1186/1475-2840-11-118

By:

Sakamoto, Masaya;
Suzuki, Hirofumi;
Hayashi, Takeshi;
Iuchi, Hiroyuki;
Isaka, Tsuyoshi;
Sakamoto, Noriko;
Kayama, Yosuke;
Tojo, Katsuyoshi;
Yoshimura, Michihiro;
Utsunomiya, Kazunori

Publication type:

Article

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.

Published in:: Cardiovascular Diabetology, 2011, v. 10, n. 1, p. 74, doi. 10.1186/1475-2840-10-74
Publication type:: Article

Benefits of renin--angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.

Published in:: Current Medical Literature: Diabetes, 2011, v. 28, n. 4, p. 141
Publication type:: Article

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled Diabetic Retinopathy Candesartan Trials.

Published in:: Current Medical Literature: Diabetes, 2011, v. 28, n. 4, p. 135
Publication type:: Article

Secondary Effects of Hypochlorite Treatment on the Emerging Pollutant Candesartan: The Formation of Degradation Byproducts and Their Toxicological Profiles.

Published in:

Molecules, 2021, v. 26, n. 11, p. 3422, doi. 10.3390/molecules26113422

By:

Luongo, Giovanni;
Saviano, Lorenzo;
Libralato, Giovanni;
Guida, Marco;
Siciliano, Antonietta;
Previtera, Lucio;
Di Fabio, Giovanni;
Zarrelli, Armando

Publication type:

Article

Study of Neuroprotection by a Combination of the Biological Antioxidant (Eucalyptus Extract) and the Antihypertensive Drug Candesartan against Chronic Cerebral Ischemia in Rats.

Published in:

Molecules, 2021, v. 26, n. 4, p. 839, doi. 10.3390/molecules26040839

By:

Trabolsi, Christine;
Takash Chamoun, Wafaa;
Hijazi, Akram;
Nicoletti, Cendrine;
Maresca, Marc;
Nasser, Mohamad;
Capasso, Raffaele

Publication type:

Article

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation.

Published in:

Molecules, 2012, v. 17, n. 11, p. 13221, doi. 10.3390/molecules171113221

By:

Vaculikova, Eliska;
Grunwaldova, Veronika;
Kral, Vladimir;
Dohnal, Jiri;
Jampilek, Josef

Publication type:

Article

L-Arginine, Asymmetric Dimethylarginine and Rhythm Outcome after Electrical Cardioversion for Atrial Fibrillation.

Published in:

Cardiology, 2011, v. 117, n. 3, p. 176, doi. 10.1159/000321402

By:

Tveit, Arnljot;
Arnesen, Harald;
Smith, Pal;
Bratseth, Vibeke;
Seljeflot, Ingebjørg

Publication type:

Article

Medical options to fight mortality in end-stage renal disease: a review of the literature.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 12, p. 4298, doi. 10.1093/ndt/gfs400

By:

Kramann, Rafael;
Floege, Jürgen;
Ketteler, Markus;
Marx, Nikolaus;
Brandenburg, Vincent M.

Publication type:

Article

Simple, Accurate and Multianalyte Determination of Thirteen Active Pharmaceutical Ingredients in Polypills by HPLC-DAD.

Published in:

Chemosensors, 2023, v. 11, n. 1, p. 25, doi. 10.3390/chemosensors11010025

By:

Żuromska-Witek, Barbara;
Stolarczyk, Mariusz;
Szlósarczyk, Marek;
Kielar, Szymon;
Hubicka, Urszula

Publication type:

Article

Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.

Published in:

Clinical & Experimental Hypertension, 2021, v. 43, n. 7, p. 597, doi. 10.1080/10641963.2021.1919357

By:

Cao, Nian;
Tang, Hui;
Tian, Miao;
Gong, Xue;
Xu, Zaicheng;
Zhou, Binqing;
Lan, Cong;
Chen, Caiyu;
Qu, Shuang;
Zheng, Shuo;
Ren, Hongmei;
Fan, Chao;
Jose, Pedro A.;
Zeng, Chunyu;
Xia, Tianyang

Publication type:

Article

A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension.

Published in:

Clinical & Experimental Hypertension, 2019, v. 41, n. 1, p. 75, doi. 10.1080/10641963.2018.1445750

By:

Zhao, Di;
Liu, Hui;
Dong, Pingshuan

Publication type:

Article

Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4<sup>+</sup>T lymphocytes in Kazakh patients with hypertension from the Xinjiang region.

Published in:

Clinical & Experimental Hypertension, 2018, v. 40, n. 4, p. 303, doi. 10.1080/10641963.2017.1377212

By:

Li, Hui;
Zhao, Jun-Ling;
Zhang, Yuan-Ming;
Han, Su-Xia

Publication type:

Article

Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials.

Published in:

Clinical & Experimental Hypertension, 2017, v. 39, n. 3, p. 257, doi. 10.1080/10641963.2016.1246564

By:

Liu, Liping;
Xu, Bing;
Ju, Yunfeng

Publication type:

Article

Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study.

Published in:

Clinical & Experimental Hypertension, 2016, v. 38, n. 2, p. 173, doi. 10.3109/10641963.2015.1081214

By:

Susa, Norio;
Nishida, Yayoi;
Yada, Yoichi;
Nakayama, Tomohiro;
Asai, Satoshi;
Takahashi, Yasuo

Publication type:

Article

Differences in 24-h blood pressure profile of Japanese hypertensive patients under ARB treatment.

Published in:

Clinical & Experimental Hypertension, 2015, v. 37, n. 7, p. 574, doi. 10.3109/10641963.2015.1026042

By:

Kita, Toshihiro;
Sakima, Atsushi;
Yokota, Naoto;
Tamaki, Noboru;
Etoh, Takuma;
Shimokubo, Toru;
Nakada, Seigo;
Takishita, Shuichi;
Ohya, Yusuke;
Kitamura, Kazuo

Publication type:

Article

Benefit of azilsartan on blood pressure elevation around rest-to-active phase in spontaneously hypertensive rats.

Published in:

Clinical & Experimental Hypertension, 2015, v. 37, n. 1, p. 45, doi. 10.3109/10641963.2014.897721

By:

Isegawa, Kengo;
Hirooka, Yoshitaka;
Kishi, Takuya;
Yasukawa, Keiji;
Utsumi, Hideo;
Sunagawa, Kenji

Publication type:

Article

Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.

Published in:

Clinical & Experimental Hypertension, 2014, v. 36, n. 1, p. 40, doi. 10.3109/10641963.2013.783052

By:

Sakima, Atsushi;
Kita, Toshihiro;
Nakada, Seigo;
Yokota, Naoto;
Tamaki, Noboru;
Etoh, Takuma;
Shimokubo, Toru;
Kitamura, Kazuo;
Takishita, Shuichi;
Ohya, Yusuke

Publication type:

Article

Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY).

Published in:

Clinical & Experimental Hypertension, 2012, v. 34, n. 4, p. 249, doi. 10.3109/10641963.2012.681081

By:

Maeda, Akinobu;
Tamura, Kouichi;
Kanaoka, Tomohiko;
Ohsawa, Masato;
Haku, Sona;
Azushima, Kengo;
Dejima, Toru;
Wakui, Hiromichi;
Yanagi, Mai;
Okano, Yasuko;
Fujikawa, Tetsuya;
Toya, Yoshiyuki;
Mizushima, Shunsaku;
Tochikubo, Osamu;
Umemura, Satoshi

Publication type:

Article

Effect of Switching from Telmisartan, Valsartan, Olmesartan, or Losartan to Candesartan on Morning Hypertension.

Published in:

Clinical & Experimental Hypertension, 2012, v. 34, n. 2, p. 86, doi. 10.3109/10641963.2011.628729

By:

Hasegawa, Hiroshi;
Takano, Hiroyuki;
Kameda, Yoshihito;
Kubota, Akihiko;
Kobayashi, Yoshio;
Komuro, Issei

Publication type:

Article

Candesartan Cilexetil.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 335, doi. 10.2165/11206300-000000000-00000

By:

Hoy, Sheridan M.;
Keating, Gillian M.

Publication type:

Article

Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.

Published in:

International Journal of Urology, 2012, v. 19, n. 5, p. 457, doi. 10.1111/j.1442-2042.2012.02965.x

By:

Aikawa, Ken;
Sakai, Takio;
Ishibashi, Kei;
Shiomi, Homare;
Sagawa, Koji;
Kumagai, Shin;
Kataoka, Masao;
Akaihata, Hidenori;
Yamaguchi, Osamu

Publication type:

Article

Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83508-2

By:

Sánchez-Rodríguez, Carmen;
Sierra, Álvaro;
Planchuelo-Gómez, Álvaro;
Martínez-Pías, Enrique;
Guerrero, Ángel L.;
García-Azorín, David

Publication type:

Article